PATRICIA
PALAU SAMPIO
TITULAR D'UNIVERSITAT
Centro Nacional de Investigaciones Cardiovasculares Carlos III
Madrid, EspañaPublications in collaboration with researchers from Centro Nacional de Investigaciones Cardiovasculares Carlos III (1)
2022
-
Short-term effects of dapagliflozin on maximal functional capacity in heart failure with reduced ejection fraction (DAPA-VO2): a randomized clinical trial
European Journal of Heart Failure, Vol. 24, Núm. 10, pp. 1816-1826